케이바이오

038530KOSDAQ생활용품 도매업

54.5 / 100

Reference Date: 2026-04-13

Financial Score25.0 / 40

News Sentiment12.5 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 8.4% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

KEBIO operates in two main sectors: bio-distribution of life science equipment and reagents, and ICT solutions including hardware, software, and IT services. Since acquiring CureBio's distribution division in 2021, the company has expanded its bio-distribution business, leveraging over 20 years of experience. Additionally, it is broadening its ICT offerings by developing IoT-based security solutions, such as large-scale integrated control systems and smart policing services, building on its expertise in video security technology.

Number of Employees

38people

Average Salary

49.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 14.254.0Point

PBR

0.36Industry Average 0.757.0Point

Half of industry avg (excellent)

ROE

-4.82Industry Average 0.060.0Point

Well below industry avg

Debt Ratio

0.33Industry Average 11.058.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲97.1% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲166.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -8.8% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (31%)

Current 317Won52-week high 51652-week low 225

1-month return1.0Point

1m -8.38% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

11 totalPositive 0Neutral 11Negative 0

Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-04-09
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
Neutral정기주주총회결과2026-03-31
Neutral대표이사변경2026-03-31
Neutral상호변경안내2026-03-31